A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant
Ceftazidime-avibactam
carbapenem-resistant Klebsiella pneumoniae
fosfomycin
meropenem
Journal
Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
3
5
2024
Statut:
aheadofprint
Résumé
The main aim of this study was to compare and analyze the effectiveness of treatment regimens using ceftazidime/avibactam (CAZ/AVI) versus fosfomycin plus meropenem (FOS/MER) for managing bloodstream infections (BSI) or ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Identifiants
pubmed: 38698711
doi: 10.1080/1120009X.2024.2349439
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM